Welcome to
Open Targets

For biomedical researchers who need to identify a biological target for a new therapy, Open Targets is a public-private initiative to generate evidence on the validity of therapeutic targets based on genome-scale experiments and analysis. Open Targets is working to create an R&D framework that applies to a wide range of human diseases, and is committed to sharing its data openly with the scientific community.

View the platform


Thursday, 15 September, 2016

Following the success of last year's Target Validation Using Genomics and Informatics conference at the Wellcome Genome Campus, where Open Targets Scientific Director Ian Dunham gave a presentation about the newly launched Target Validation Platform, we are excited about the upcoming second conference taking place at EMBL Heidelberg, Germany on 4 - 6 December 2016.